PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) Notes Receivable: Rp0.00 Mil (As of . 20)


What is PT Brigit Biofarmaka Teknologi Tbk Notes Receivable?

PT Brigit Biofarmaka Teknologi Tbk ISX:OBAT Notes Receivable is Rp0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

PT Brigit Biofarmaka Teknologi Tbk's Notes Receivable for the quarter that ended in . 20 was Rp0.00 Mil.

PT Brigit Biofarmaka Teknologi Tbk Notes Receivable Related Terms

PT Brigit Biofarmaka Teknologi Tbk Notes Receivable Historical Data

* Premium members only.

The historical data trend for PT Brigit Biofarmaka Teknologi Tbk's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Brigit Biofarmaka Teknologi Tbk Notes Receivable Chart

PT Brigit Biofarmaka Teknologi Tbk Annual Data
Trend
Notes Receivable

PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Notes Receivable

PT Brigit Biofarmaka Teknologi Tbk Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of Rp0.00 Mil mean?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Notes Receivable of Rp0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors.
Is PT Brigit Biofarmaka Teknologi Tbk's Notes Receivable too high?
PT Brigit Biofarmaka Teknologi Tbk's current Notes Receivable is Rp0.00 Mil.
How does PT Brigit Biofarmaka Teknologi Tbk's Notes Receivable compare to KHC and GIS?
PT Brigit Biofarmaka Teknologi Tbk's Notes Receivable of Rp0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. PT Brigit Biofarmaka Teknologi Tbk's current Notes Receivable is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Notes Receivable of Rp0.00 Mil. The current Notes Receivable is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Notes Receivable is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Brigit Biofarmaka Teknologi Tbk Business Description

Address Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan, Tawangsari, Kab. Sukoharjo, Jawa Tengah, IDN, 57561
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.